- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07710859
Concentric vs Eccentric Exercise in Blood Flow Restriction Training
Comparison of the Effectiveness of Concentric and Eccentric Exercises in Blood Flow Restriction Training
This randomized controlled trial will investigate the effects of blood flow restriction (BFR) training combined with concentric or eccentric exercise on upper extremity reaction speed, muscle strength, and muscle oxygenation in healthy adults aged 18-35 years. A total of 34 participants will be randomly allocated to either a BFR combined with concentric exercise group (n=17) or a BFR combined with eccentric exercise group (n=17).
Before the intervention, maximal muscle strength will be determined using a one-repetition maximum (1RM) test for the dominant elbow flexor muscles. Upper extremity reaction speed will be assessed using the Nelson Hand Reaction Test. Biceps brachii muscle strength will be measured with a digital dynamometer, and muscle oxygenation will be evaluated using a near-infrared spectroscopy (NIRS) device. All outcome measures will be obtained 72 hours before the intervention and repeated 72 hours after completion of the training program by the same investigator.
The findings of this study will contribute to understanding whether concentric or eccentric exercise combined with BFR training provides greater improvements in upper extremity reaction speed, muscle strength, and muscle oxygenation in healthy individuals.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Karabük Province
-
Karabük, Karabük Province, Türkei (türkiye), 78050
- Karabuk university
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Being between 18 and 35 years of age
- Physically inactive or minimally active individuals (International Physical Activity Questionnaire-Short Form. IPAQ-CF, <3000 MET-min/week)
Exclusion Criteria:
- Having a history of musculoskeletal surgery within the last 6 months
- Individuals with a history of orthopedic surgery within the last 6 months
- Having high systolic blood pressure (≥140 mmHg)
- Having a current history of cardiovascular disease
- Participants who did not volunteer to participate in the study and did not provide informed consent were excluded from the study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: CONCENTRIC GROUP
|
Participants assigned to this group will perform blood flow restriction (BFR) training combined with concentric elbow flexion exercises using the dominant upper extremity.
Training will be performed three times per week for four weeks (12 sessions).
Exercises will be performed at 20-30% of one-repetition maximum (1RM) using a pneumatic cuff applied to the proximal upper arm.
The cuff pressure will be set at 50% of the individual's arterial occlusion pressure.
Each session will consist of four sets (30-15-15-15 repetitions) with 30-second rest intervals between sets.
Participants assigned to this group will perform blood flow restriction (BFR) training combined with eccentric elbow flexion exercises using the dominant upper extremity.
Training will be performed three times per week for four weeks (12 sessions).
Exercises will be performed at 20-30% of one-repetition maximum (1RM) using a pneumatic cuff applied to the proximal upper arm.
The cuff pressure will be set at 50% of the individual's arterial occlusion pressure.
Each session will consist of four sets (30-15-15-15 repetitions) with 30-second rest intervals between sets.
|
|
Aktiver Komparator: ECCENTRIC GROUP
|
Participants assigned to this group will perform blood flow restriction (BFR) training combined with concentric elbow flexion exercises using the dominant upper extremity.
Training will be performed three times per week for four weeks (12 sessions).
Exercises will be performed at 20-30% of one-repetition maximum (1RM) using a pneumatic cuff applied to the proximal upper arm.
The cuff pressure will be set at 50% of the individual's arterial occlusion pressure.
Each session will consist of four sets (30-15-15-15 repetitions) with 30-second rest intervals between sets.
Participants assigned to this group will perform blood flow restriction (BFR) training combined with eccentric elbow flexion exercises using the dominant upper extremity.
Training will be performed three times per week for four weeks (12 sessions).
Exercises will be performed at 20-30% of one-repetition maximum (1RM) using a pneumatic cuff applied to the proximal upper arm.
The cuff pressure will be set at 50% of the individual's arterial occlusion pressure.
Each session will consist of four sets (30-15-15-15 repetitions) with 30-second rest intervals between sets.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Upper Extremity Reaction Time
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Upper extremity reaction time will be assessed using the Nelson Hand Reaction Test.
Participants will complete five trials, the highest and lowest values will be discarded, and the mean of the remaining three trials will be used for analysis.
Reaction time will be calculated from the ruler drop distance using the standard equation.
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
|
Biceps Brachii Muscle Strength
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Biceps brachii muscle strength will be measured using an ActivForce 2 digital dynamometer.
Three maximal isometric contractions will be performed with 30-second rest intervals, and the highest value will be used for analysis.
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
|
Hand Grip Strength
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Hand grip strength will be measured using a hydraulic hand dynamometer.
Participants will perform three maximal contractions with 30-second rest intervals, and the highest value will be recorded for analysis.
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
|
Pinch Strength
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Pinch strength will be assessed using a pinch dynamometer.
Three maximal trials will be performed with 30-second rest intervals, and the highest value will be used for analysis.
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
|
One-Repetition Maximum
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Maximum muscle strength of the elbow flexors will be estimated using the Epley equation based on the maximum number of repetitions completed with a fixed load (2 kg for females and 5 kg for males).
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
|
Muscle Oxygen Saturation
Zeitfenster: Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Muscle oxygen saturation (SmO₂) of the biceps brachii will be measured using a MOXY near-infrared spectroscopy (NIRS) device.
Baseline SmO₂ will be recorded before the 1RM test, continuous SmO₂ values will be monitored throughout the test, and recovery values will be recorded for 2-3 minutes after the test.
|
Baseline (72 hours before the intervention) and 72 hours after completion of the 4-week intervention.
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- blood flow restriction
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur concentric group
-
Hui-Hsun ChiangAbgeschlossenErziehungsprobleme | Pflege | Gewalt am ArbeitsplatzTaiwan
-
Ataturk UniversityAktiv, nicht rekrutierend
-
The University of Hong KongRekrutierung
-
Batman UniversityAbgeschlossenWechseljahre | Übergewichtige Patienten | Lebensqualität und Wechseljahre | Pilates-ÜbungTruthahn
-
Samsung Medical CenterRekrutierungArthroplastik, Ersatz, Schulter | Umgekehrte totale SchulterendoprothetikKorea, Republik von
-
Trakya UniversityNoch keine RekrutierungSchmerz- und emotionale Reaktionen bei Kindern während der venösen Blutentnahme
-
Erzurum Technical UniversityNoch keine RekrutierungLymphödem | Ödem | Frühgeburt | Immobilisierung
-
Chinese University of Hong KongSocial Welfare Department, Hong KongNoch keine RekrutierungAutismus-Spektrum-Störung | Dyslexie | Aufmerksamkeitsdefizitstörung mit Hyperaktivität (ADHS) | Neurologische Entwicklungsstörung (Diagnose)
-
University of Illinois at ChicagoPatient-Centered Outcomes Research Institute; University of ChicagoRekrutierungSchwangerschaftskomplikationen | Patientenbindung | Muster der mütterlichen FürsorgeVereinigte Staaten
-
Aydin Adnan Menderes UniversityAbgeschlossenSchmerztherapie | Primäre DysmenorrhoeTürkei (türkiye)